Warren, New Jersey-based Aquestive Therapeutics Inc, a specialty pharmaceutical company, has raised $67.5 million for its IPO after pricing its 4.5 million shares at $15 per share. The stock began trading July 25, 2018 on the NASDAQ under the ticker symbol "AQST." BMO Capital Markets and RBC Capital Markets are the lead underwriters. Aquestive Therapeutics' pre-IPO backers include Bratton Capital Management.
Focus Financial, KKR, Stone Point Capital, private equity, financial services, wealth management, merger, m&a
Stone Point and KKR acquired Focus in July 2017 Stone Point is investing out of Trident VII, which closed on $5.5 bln in 2017 Focus is a partnership of wealth-management firms Focus Financial Partners is expected to go public later this month, just a year since it was sold to KKR and Stone Point Capital. […]
Canadian cannabis firm Tilray, a portfolio company of Privateer Holdings, has raised about $153 million for its IPO after pricing its 9 million shares at $17 per share. The stock began trading July 19, 2018 on the NASDAQ under the ticker symbol "TLRY." Cowen and BMO Capital Markets are the lead underwriters. Tilray is not trading on any Canadian stock exchange.
Aritzia Inc (TSX: ATZ), a Vancouver-based women’s fashion brand, said U.S. private equity firm Berkshire Partners and another investor will sell subordinate voting shares for $16.55 per unit. The secondary offering is expected to generate proceeds of more than $100 million or more than $115 million if the greenshoe option is exercised in full. Upon completion of the offering, and assuming no exercise of the greenshoe option, Berkshire will hold about 22.4 percent of issued and outstanding shares and about 45.1 percent of the voting power attached to all of the shares. Aritzia went public in 2016, raising $460 million. Berkshire acquired the company in 2005.
Chinese online group discounter Pinduoduo plans to raise up to $1.63 billion from a U.S. listing, its latest filing with the U.S. Securities and Exchange showed, in what would be the second-biggest U.S. float by a Chinese firm this year, Reuters reported.
MAV Beauty Brands Inc, the holding company for Toronto-based beauty specialist Marc Anthony Cosmetics Inc, has closed its initial public offering in Canada. The company raised about $242 million in treasury and secondary proceeds. As reported last month by PE Hub Canada, the IPO’s forthcoming greenshoe option could bring total proceeds to as much as $278 million. Marc Anthony's common shares will begin trading today on the Toronto Stock Exchange under the symbol MAV. Founded in 1995 and led by Marc Anthony Venere, Marc Anthony develops, markets and distributes hair-care and body-care products. It was acquired in 2016 by U.S. private equity firm TA Associates.
Houston-based AFGlobal, an original equipment manufacturer, has priced its IPO of 18.2 million shares at a price between $15 and $18 per share. The stock will trade on the New York Stock Exchange under the ticker symbol “AFGL." Goldman Sachs, Credit Suisse Securities (USA) LLC and Piper Jaffray & Co. are the lead underwriters. AFGlobal's backers include First Reserve and The Carlyle Group.
Tilray, a Nanaimo, British Columbia-based cannabis cultivator, processor and distributor, has priced its recently filed initial public offering in the United States. Tilray, which plans to list on the Nasdaq Global Select Market under the symbol TLRY, is selling Class 2 common stock at an initial price of US$14 to US$16 per unit. The IPO is expected to raise as much as US$165.6 million ($217 million) in proceeds, assuming its greenshoe option is fully exercised. Founded in 2014, Tilray is owned by U.S. cannabis private equity firm Privateer Holdings. Earlier this year, the company closed a $60 million Series A financing backed by unidentified institutional investors.
Canadian medical cannabis producer Tilray has priced its IPO of 9 million shares at a price between $14 and $16. The company is planning on trading its stock on the NASDAQ under the ticker symbol “TLRY.” Cowen and BMO Capital Markets are the lead underwriters. Tilray does not plan on trading the stock on any Canadian stock exchange. Tilray is a portfolio company of Privateer Holdings.
Public listing preparations of state-run Saudi Aramco have stalled, the Wall Street Journal reported on Thursday.
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination